Key terms

About STRO

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest STRO news

Apr 03 9:26am ET Sutro Biopharma price target lowered to $18 from $25 at Truist by TipRanks Apr 03 8:01am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Apr 03 7:21am ET Sutro Biopharma price target lowered to $11 from $12 at Piper Sandler by TipRanks Apr 03 7:06am ET Piper Sandler Keeps Their Buy Rating on Sutro Biopharma (STRO) by TipRanks Apr 03 12:35am ET Sutro Biopharma Buy Rating Justified by Strategic Partnerships and Promising Pipeline by TipRanks Apr 02 7:43am ET Sutro Biopharma 14.479M share Spot Secondary priced at $5.18 by TipRanks Apr 02 6:23am ET Sutro Biopharma Secures Major Deal with Ipsen for STRO-003 by TipRanks Apr 01 1:52am ET Sutro Biopharma (NASDAQ:STRO): Intriguing Play for Biotech Investors by TipRanks Mar 28 10:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 26 8:30am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 26 4:47am ET Sutro Biopharma: A Stable Hold Amid Pipeline Execution and Short-Term Uncertainties by TipRanks Mar 26 12:25am ET Sutro Biopharma Buy Rating Affirmed on Strong Financials and Promising Clinical Pipeline by TipRanks Mar 25 10:15pm ET TD Cowen Sticks to Its Buy Rating for Sutro Biopharma (STRO) by TipRanks Feb 29 6:29am ET Sutro Biopharma: A Balanced Hold Rating Amid Pipeline Execution and Upcoming Data Catalysts by TipRanks Feb 10 4:42am ET Sutro Biopharma Expands Share Offering, Raises $129M by TipRanks Jan 22 3:50pm ET Analysts Offer Insights on Healthcare Companies: Codexis (CDXS), Leap Therapeutics (LPTX) and Sutro Biopharma (STRO) by TipRanks Jan 08 5:06am ET Sutro Biopharma: Hold Rating Maintained Amid Near-Term Uncertainties and Market Potential Ambiguities by TipRanks Jan 05 6:27am ET Buy Rating Justified: Sutro Biopharma’s Luvelta Shows Promise in PROC Treatment and Beyond by TipRanks Jan 04 4:28pm ET Sutro Biopharma: Multi-cancer opportunity for FolRa-targeting ADC Luvelta by TipRanks

No recent press releases are available for STRO

STRO Financials

1-year income & revenue

Key terms

STRO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

STRO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days